期刊文献+

恩施地区乙型肝炎患者HBV DNA YMDD变异的检测 被引量:3

Detection of HBV DNA YMDD Mutation in Patients with Chronic Hepatitis B in Enshi Autonomous Prefecture
下载PDF
导出
摘要 目的了解恩施地区慢性乙型肝炎(乙肝)患者HBV DNA YMDD变异的情况。方法检测该地区100例乙肝患者ALT水平、HBV DNA载量、HBV YMDD变异,对其HBV DNA YMDD变异情况进行分析。结果 100例乙肝患者中检出HBV DNA YMDD变异共15例(阳性率15%),已服用拉米夫定者60例,检出YMDD变异12例(阳性率20%),未服用拉米夫定患者40例,检出YMDD变异3例(阳性率7.5%)。15例YMDD变异患者HBV DNA在5.21×10^4-1.34×10^8copies/ml,ALT水平在38-1100U/L。结论恩施地区乙肝患者YMDD变异可在拉米夫定治疗过程中出现,也可天然存在;尚未发现恩施地区乙肝患者性别、年龄、HBV DNA载量。 Objective To investigate the existence of HBV DNA YMDD mutation in patients with chronic hepatitis B in Enshi Autonomous prefecture.Methods The ALT level,HBV DNA,and HBV DNA YMDD mutation in the patients with chronic hepatitis B were detected and analyzed.Results HBV DNA YMDD mutation was found in 15 out of 100 patients with hepatitis B(positive rate 15%).HBV DNA YMDD mutation was found in 12 out of 60 patients receiving lamivuding therapy(positive rate 20%),but HBV DNA YMDD mutation was found in 3 out of 40 patients without lamivuding therapy(positive rate 7.5%).In the 15 patients with HBV DNA YMDD mutation,HBV DNA and ALT level were 5.21×10^4~1.34×10^8 copies/ml and 38~1100 U/ L respectively.Conclusion The existence of HBV DNA YMDD mutation in patients with chronic hepatitis B in Enshi Autonomous Prefecture may occur during the process of lamivuding therapy or may exist naturally.The existence of HBV DNA YMDD in patients with chronic hepatitis B mutation in Enshi Autonomous Prefecture is unrelated with gender,age,serum viral load or ALT level.
出处 《湖北民族学院学报(医学版)》 2010年第3期47-49,共3页 Journal of Hubei Minzu University(Medical Edition)
关键词 恩施地区 慢性乙型肝炎 YMDD变异 拉米夫定 Enshi autonomous prefecture chronic hepatitis B YMDD mutation lamivudine
  • 相关文献

参考文献5

二级参考文献48

  • 1Ayman A Abdo,Badr M Al-Jarallah,Faisal M Sanai,Ahmad S Hersi,Khalid Al-Swat,Nahla A Azzam,Manal Al-Dukhayil,Amira Al-Maarik,Faleh Z Al-Faleh.Hepatitis B genotypes: Relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia[J].World Journal of Gastroenterology,2006,12(43):7019-7024. 被引量:7
  • 2Hans L Tillmann.Antiviral therapy and resistance with hepatitis B virus infection[J].World Journal of Gastroenterology,2007,13(1):125-140. 被引量:45
  • 3[1]Maddrey WC.Hepatitis B-an important public health issue.Clin Lab 2001; 47:51-55
  • 4[2]Lai CL,Ratziu V,Yuen MF,Poynard T.Viral hepatitis B.Lancet 2003; 362:2089-2094
  • 5[3]Manigold T,Rehermann B.Chronic hepatitis B and hepatocarcinogenesis:does prevention of "collateral damage"bring the cure? Hepatology 2003; 37:707-710
  • 6[4]Lai CL,Chien RN,Leung NW,Chang TT,Guan R,Tai DI,Ng KY,Wu PC,Dent JC,Barber J,Stephenson SL,Gray DF.A one-year trial of lamivudine for chronic hepatitis B.Asia Hepatitis Lamivudine Study Group.N Engl JMed 1998; 339:61-68
  • 7[5]Leung NW,Lai CL,Chang TT,Guan R,Lee CM,Ng KY,Lim SG,Wu PC,Dent JC,Edmundson S,Condreay LD,Chien RN.Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates:results after 3 years of therapy.Hepatology 2001; 33:1527-1532
  • 8[6]Yuen MF,Lai CL.Treatment of chronic hepatitis B.Lancet Infect Dis 2001; 1:232-242
  • 9[7]Hu KQ.A Practical Approach to Management of Chronic Hepatitis B.Int J Med Sci 2005; 2:17-23
  • 10[8]Allen MI,Deslauriers M,Andrews CW,Tipples GA,Walters KA,Tyrrell DL,Brown N,Condreay LD.Identification and characterization of mutations in hepatitis B virus resistant to lamivudine.Lamivudine Clinical Investigation Group.Hepatology 1998; 27:1670-1677

共引文献14047

同被引文献27

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部